# Aprea Therapeutics, Inc.

Type: Company (APRE)

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/aprea-therapeutics-inc
Canonical HTML page: https://getlegalbrief.com/entity/aprea-therapeutics-inc

## Recent coverage (1 stories)

### Aprea Builds 58-Patent Wall as WEE1 Portfolio Runs to 2047
2026-08-29 02:21:38 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Aprea's latest disclosure outlines a multi-jurisdictional patent estate spanning 28 issued and 30 pending patents, with WEE1 filings extending to 2047. The move strengthens exclusivity and signals an aggressive IP-defense strategy in precision oncology.
Full story: https://getlegalbrief.com/story/aprea-ip-portfolio-2047-wee1-patent-strategy

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.